Updated on January 13, 2026, 09:50PM (AST)

05.01.2026, 13:13

Kazakhstan to build $220 mln biopharma plant, targeting domestic and export markets


ALMATY. Jan 5 (Interfax-Kazakhstan) — The Kazakh government has approved a major investment to build a 103-billion-tenge biopharmaceutical complex in the Almaty region, the Cabinet’s press service announced Monday.


To read the full news articles, Subscribe.

















Archive

Error message here!

Show Error message here!

Close